2,431
Views
16
CrossRef citations to date
0
Altmetric
Health Policy

Does the critical illness insurance reduce patients’ financial burden and benefit the poor more: a comprehensive evaluation in rural area of China

, , , , , & show all
Pages 455-463 | Received 10 Dec 2018, Accepted 23 Jan 2019, Published online: 08 Mar 2019

Abstract

Background: Critical illness insurance (CII) is one kind of health insurance that is gradually gaining attention worldwide. China implemented CII in 2012 to decrease patients’ out-of-pocket (OOP) medical payments. The aims of this study were to determine if the project had positive impacts on relieving financial burden and improving health equity.

Methods: A series of questionnaire surveys were undertaken in two counties before and after the intervention in rural China. OOP expenditure, catastrophic Health Expenditure (CHE) incidence, and associated average gap (AG) were assessed across different income groups and project durations, measuring short-term direct medical cost. Medical debt rate and amount were used to measure long-term financial burden; concentration index (CI) was calculated for equity. All data were evaluated by descriptive statistics and multi-variate variance analysis. The linear regression and logit regression with random effect analysis upon area was used to evaluate the effect of CII.

Results: Six hundred and thirteen and 834 patients were surveyed at baseline and final evaluation. After the program, the OOP payments of hospitalizations sharply decreased from RMB 39,363.2 to RMB 28,426.1 (p < 0.001), with the largest decrease for lowest income patients (from RMB 44,507.6 to RMB 29,214.2). With longer duration of CII, more OOP medical payments decreased. The amount of medical debt was decreased by RMB 7,209.4 among all the patients, and the decrease was highest in the highest income group (RMB 8,119.9). The CI of AG changed a lot (from −0.858 to −0.670).

Conclusion: The CII has effectively reduced the financial burden of patients with high medical cost, whether in the short-term or a longer length of time. It also improved health equity in health service utilization and expenditure. However, rich householders still receive more benefits from the policy, government health insurance financing is increased, and the policy needs to further benefit the poor.

JEL CLASSIFICATION CODES:

Introduction

Critical illness insurance (CII) is one kind of health insurance, but different from common ones, which specially focus on patients diagnosed with severe and/or critical diseasesCitation1,Citation2. In the early 1980s, CII first came to the scene as “Dread Disease Insurance” in South Africa. It has achieved great success as it filled the gap of no coverage for expensive medical expensesCitation3. CII was also implemented in the UK and began to flourish by combining dread disease cover and income protection in the early 1990s. Since then, more countries have begun to practice CII, including the US, Canada, and Australia. In America and the UK, CII provides a single lump sum payment to the insured, including medical costs and non-medical financial costs, such as mortgages and creditsCitation4. Patients with critical illness would get $10,000 or $20,000 in Initial Benefits from an insurance company in 2017 in the USCitation5. Today, CII cover has a considerable market share in Asian insurance marketsCitation6.

In rural China, the New Cooperative Medical Scheme (NCMS), a voluntary insurance scheme designed for rural residents, was founded in 2003. The enrollment rate of NCMS gradually increased and had achieved 98.8% in 2015. Although the main objective of NCMS is to prevent rural residents from being impoverished by medical expenses, many problems, reflected on financial burden and equity, still exist. Wagstaff et al.Citation7 found that the NCMS took no effects on reducing out-of-pocket (OOP) payments. Cheng et al.Citation8 also proved that the financial protection of NCMS against high healthcare expenditures remained very restricted among the poor in rural China. Meanwhile, Ma et al.Citation9 found NCMS expanded the gap of income-related inequity in rural China.

To further reduce the financial burden of patients with critical diseases and improve the equity between the rich and the poor, on August 30, 2012, China’s National Development and Reform Commission issued the “Guidance about implementation of residents’ critical illness insurance system”. The guidance points out that critical illness insurance (CII) is an institutional arrangement aimed at providing reimbursement of high medical expenses associated with critical illness. At the beginning, the CII only covered 20 officially critical diseases, such as congenital heart disease, breast cancer, and end-stage renal failure. As of February 2014, 25 provinces had established CII systemsCitation10. China’s government gradually transformed from a disease-based principle to a fee-based principle. In other words, after claiming basis health insurance, all the patients whose OOP still exceeded the deductible, usually the local income per capita, could obtain additional reimbursement, regardless of what the disease isCitation11, the average reimbursement rate was ∼ 50–70%.

The research on medical insurance for CII was mostly taken in developing countries, focused on how to improve the health insurance system to alleviate the economic risk of critical disease. KasemsupCitation12 showed that the extent of critical illness protection should be adjusted based on factors such as the type of disease, age, treatment effect, emergency, waiting time, and ability to pay in Thailand. Chuma and MainaCitation13 took Kenya as an example and recommended that, in addition to inpatient services, outpatient services should be included in the CII service package. In China, due to the short implementation time of CII, the current research was focused on the analysis of the insurance system, from the institutional attributes of the CII to the design of the program and so onCitation14. However, few studies clearly answer the question: whether the implementation of CII filled the gap caused by basic health insurance on the aspects of financial burden and health equity, especially among rural residentsCitation15.

Financial burden includes two aspects. First, the direct medical cost resulted from the cost of the health services patient utilized including consultations, tests, medicines, and hospitalization, etc.Citation16 This financial burden is easy to measure. The OOP and catastrophic health expenditure (CHE) are the commonly used indexes. Second, indirect medical cost of income lost and direct non-medical cost of transport and food during healthcare visitsCitation17. This financial burden is hard to measure. In practice, the indirect medical cost and non-medical cost can be bigger than direct medical cost, and may mean a bigger policy gap. Financial burden, in another view, includes short-term burden and long-term burden. The usually used indicators, such as actual health expenditures and amount of expenditures relative to income, respond more to the short-term burden of the patient within 1 yearCitation18–20. Studies indicated that the accumulated long-term burden can be serious and under-researchedCitation21,Citation22. But few studies give a comprehensive evaluation when they focus on the policy’s effect on financial burden.

Equity includes horizontal equity and vertical equity. Kaplow and Musgrave define horizontal equity (HE) as the requirement that equals be treated alike. Both define vertical equity (VE) as requiring an “appropriate” pattern of differentiation among unequalsCitation23. Due to the availability of methods, there is still no mature method to measure vertical equity.

Ensuring everyone can have access to health services without facing financial hardship is the principle of the Universal Health Coverage (UHC). In addition, ensuring equity when people access health services is a major concern in health policyCitation24. In this study, we will give a comprehensive evaluation of CII on financial burden and equity in the rural areas of China. The questions we want to answer are (1) whether the CII decreased the short-term and long-term financial burden of patients; (2) whether the CII decreased the whole burden with patients had less unoccupied health utilization; and (3) if CII do reduce the economic burden, does it have the same effect on the rich and the poor. Our findings quantitatively assessed CII performance relative to the goal of offering financial protection against poverty, and may contribute to improving and adjusting CII policy, thereby further relieving the inequity in healthcare.

Methods

Introduction of sample setting and the policy of CII

Study setting

According to the study by Meng et al.Citation25, households in the central and west region are more likely to suffer from higher rates of catastrophic health spending. The percentage of households experiencing catastrophic health expenses was 13.7% in central China, 13.3% in the west region, compared to 11.9% in the east region. Thus, we selected one county for research in the central and western regions, respectively. Based on the availability of data, we selected Hubei Province in the central part and Guizhou Province in the west as the sampling area. In these two provinces, we randomly selected two sample counties: Xiantao county and Yuqing county.

Hubei province is in central China and the middle reaches of the Yangtze River. It had a gross domestic product (GDP) per capita of Renminbi (RMB)55,665 (8,383 USD) in 2016, which ranks it 11th among the 32 provinces (municipalities and autonomous regions) in China. Xiantao, where this study sample was drawn, is a county in Southwest Hubei. It had a GDP per capita of RMB 56,065 (8,438 USD) in 2016. Guizhou province is located in western China with poor resources. The GDP per capita was RMB 33,242(5,006 USD) in 2016, and ranks it 29th among the 32 provinces. Yuqing is a county with a GDP per capita of RMB 31,503 (4,744 USD).

CII Policy in sampled cities

Both sampled cities customized their own CII project under the local context. In Xiantao, CII started in 2015, the official premium is 12,000 yuan, and the reimbursement rate is 55% for OOP located for RMB 12,000–30,000, 65% for RMB 30,000–100,000, and 70% for over RMB 100,000. For example, if a patient’s medical expenses were 60,000 in Xiantao, and supposed all medical expenses were included in the benefit package, and NCMS could cover 30,000. In the baseline period, the patient’s out-of-pocket expenses would be 30,000 yuan (60,000 – 30,000), while in the final stage the patient's out-of-pocket expenses would be RMB 20,100 (60,000 – 30,000 – (30,000 – 12, 000) *55%). Yuqing started CII in 2016. Due to the different local economic conditions, the deductible was 8,000 in Yuqing, and the reimbursement rate was 50% in RMB 8,000–RMB 60,000 and 60% when OOP was over 60,000.

Data collection

Data were obtained from cross-sectional surveys at the baseline of the program in 2014 and a final evaluation in 2017. The inclusion criterion for the for the final evaluation that patients benefited from CII in the past year (2016). In order to ensure the comparability of the research objects before and after the implementation of CII, the deductible in final stage was discounted to calculate the hypothetical deductible in baseline, and then select the patients who exceeded the deductible in the current year. In 2016, the number of CII beneficiaries of Xiantao and Yuqing were 4,137 and 935, respectively. According to the economic development of the sample county, all townships are divided into good, middle, and poor categories. Patients were selected from the stratified cluster sampling of each type of township in the extraction of 2–5 townships. Five hundred patients were surveyed in two regions before and after the implementation of CII, for a total of 2,000 patients.

The survey was done with a structured questionnaire, which was constructed with reference to the National Health Services Survey Questionnaire and China Health and Retirement Longitudinal Study (CHALS) Questionnaire. Face-to-face interviews were conducted by trained investigators using a structured survey questionnaire which collected basic demographic information and data on socio-economic status, treatment procedures, and expenditures. All questionnaires were checked on site for completeness and internal logic, and they were captured for analysis using a double-entry procedure in Epi-Data.

Financial burden measurement

Measuring financial burden

  • OOP. Comprised the expenses below the deductible, the expenses above the deductible co-paid by patients, and the non-reimbursable amount beyond the NCMS benefit packages.

  • Ratio of OOP to income. Household income was the aggregate of household income from production, wage incomes of household members, transfer income (pensions, remittances, welfare), and property income (interest, rent)Citation25. Each family’s income was calculated by summing incomes across individual household members.

  • Prevalence of Catastrophic health expenditure (CHE). The criteria to define the CHE varies from 10% of income, 10% of household consumption, to 40% of disposable incomeCitation26–28. In this paper we regarded OOP in excess of 10% of annual family income as CHE, because the daily consumption of rural residents, such as food expenditure, cannot be accurately measured. Prevalence of CHE is the ration of the number of families with CHE divided by total amount of sampled families.

  • Average gap of CHE. Reflected the extent of the impact of CHE on society as a whole. It describes how much a patient’s medical expenditure (as a percentage of their annual income) is in excess of the catastrophic threshold of 10% of annual incomeCitation29. AGCHE=P10%/N where AG refers to the average gap of CHE, p is the proportion of OOP cost as a percentage of the annual income of patients who incur CHE, and N is the total number of patients in the sample.

  • Relative gap of CHE. Reflected the extent of the impact of CHE on families who had CHECitation30. The equation was: RGCHE=P10%/Nr

    where RG refers to the relative gap of CHE, p is the proportion of OOP cost as a percentage of the annual income of patients who incur CHE; and Nr is the total number who had CHE.

  • Medical debt. The above indicators respond more to the short-term burden of the patient within 1 year. Medical debt rate and the average amount of medical debt were adopted to measure long-term financial burden. Borrowing can be at high rates of interest, so choosing that may sacrifice future income and put the family in persistent povertyCitation31.

Measuring patient health utilization

In this paper, we use health service utilization indicators to indirectly reflect the whole financial burden. The principle behind this is that the use of health services and the economic burden are closely related. Patients may have forgone medical care due to high costCitation32. Therefore, in the case of constant health needs, the increase of health service utilization must result from the reduction of financial burden. The indicators adopted are frequency of hospital admissions per patient per year, average length of stay per patient per year, and the percentage of forgoing treatment or discharge early because of financial burden (underuse of impatient services) in the past year.

Equity measurement

Concentration index (CI) is a widely used index to measure equality, and need standardized CI is commonly used to measure horizontal equity. High income people usually have low needs, while low income people usually have high needs. Due to the unavailability of need data, in this paper, we just calculated CI. The effect of CII on the horizontal equity was speculated by the CI and income. CI was calculated using the following equation: CI=2Nμi=1Nhiri11N where hi represents the variable we cared, μ is its mean, and ri=i/N is the fractional rank of income, ranging from 0–1. For one individual ranked i, ri = (i − 0.5)/N, in which N is the total number of individuals.

The CI is bounded between −1 and 1. It takes positive (negative) values when the concentration curve lies below (above) the diagonal. This means that a positive (negative) value corresponds to inequalities favoring the rich (poor)Citation33.

Statistical analysis

General characteristics, including gender, marriage, education, jobs, and length of stay (LOS), impatient frequency, etc. were examined at baseline and at final evaluation using descriptive statistics. Considering the susceptibility of disease, illness category was determined by the patient’s primary diagnostic ICD10 code in the visit record. In order to explore the CII’s potential differential impact on patients from different income groups, especially the effect on the poorest patients that are most susceptible to financial difficulty, patients were categorized based on quartiles of their household income as low income group, middle income group, and high income group. We performed a normality test on all variables and selected appropriate statistical method based on the data distribution. Chi-square tests, T-tests, rank sum test, and Fisher’s exact probability were used to assess the differences in variables upon sub-groups. p < 0.05 was considered to be statistically significant. All currency-related metrics have been discounted

Linear regression and logit regression were used to evaluate the impact of CII for OOP with control of other independent variables. Since OOP is a right skewed distribution, we take the logarithm of OOP in linear regression. Random effect analysis upon counties was included in regression that would have taken into consideration the correlated nature of samples measured from the same county. Considering that two chosen counties have a different duration of experiencing CII, OOP changes upon the duration of CII implementation was also assessed. We used Stata 12.0 to conduct the quantitative data analyses.

Results

Six hundred and thirteen and 834 patients were surveyed at baseline and final evaluation. The socio-economic characteristics of patients were similar in both samples, except for their employment, income, hospital level, and area (). At baseline, 46% patients had jobs including farming, but only 27.9% of patients worked in the final stage. Meanwhile, the average household income of patients was RMB 53,219.5 (RMB 650 = US$100) in baseline compared to RMB 31,986.4 at final evaluation (p < 0.001). After program implementation, 74.3% of patients went to the higher level medical institutions outside the county for treatment. Chronic diseases accounted for the most part of all patients.

Table 1. Patient characteristics before and after intervention (%).

After program implementation, the out-of-pocket payments of all patients in hospitalizations sharply decreased from RMB 39,363.2 to RMB 28,426.1, with lowest income patients having the largest decrease (from RMB 44,507.6 to RMB 29,214.2). All changes were statistically significant (p < 0.001). High income patients had a greater decrease in CHE incidence, with rates decreases of 2.4 and 0.4 percentage points, respectively. The average gap of CHE decreased in the most poverty group (−11.8), but increased in the middle-income group (0.7). The result of the relative gap of CHE was similar to the average gap ().

Table 2. Patients financial burden at baseline and final evaluation (by income group).

shows the proportion of having medical debt increased from 62.8% to 69.1% (p < 0.001), where the lowest income group had the least change (from 64.7% to 64.9%, p = 0.969). But the amount of medical debt was decreased by RMB 7,209.4 among all patients, and the highest income group had the largest change (decreased by RMB 8,119.9, p = 0.756).

Table 3. Medical debt rate and amount at baseline and final evaluation (by income group).

After program implementation, utilization of inpatient services increased, but to different extents in different income groups. The frequency of hospital admissions significantly increased from 2.6 to 4.6 among all patients (p < 0.001), and the increase was greatest for patients with low income (p = 0.001). Length of stay showed the same change. The underuse of impatient services decreased from 16.2% to 14.9%, with the least change in low income group (from 20.9% to 19.9%, p = 0.778) ().

Table 4. Inpatient service utilization at baseline and final evaluation (by income group).

The CI of OOP payments and AG were all negative in baseline and final stage, indicating that all cases OOP payments and average gap were pro-poor. After program implementation, the CI of OOP payment changed from −0.045 to −0.035, the CI of average gap increased by 0.188 (). This change clearly shows that harsh economic effects of critical illness on poorer populations were better than before with a lower absolute value after the intervention. But the CI of AG was −0.670 in final stage, indicating a strong, pro-poor inequity.

Table 5. Concentration Index of indicators before and after the intervention.

Table 6. The linear regression of log out-of-pocket and logit regression of CHE and debt incidence with random effect analysis upon area.

clearly shows that implementation of the CII was associated with a significant decrease in OOP medical expenditure (p < 0.001). It is also notable that having chronic illness and seeking healthcare out of the county was associated with high OOP medical payments. The CII also has intensified the occurrence of CHE (p < 0.05). Seeking healthcare out of the county and having acute disease would attribute to high CHE incidence, more family members, and hospitalization times leading to higher medical debt incidence. For areas CII implemented for 2 years (Xiantao), the OOP payments declined by RMB 18,016.2, accounting for 35.69% of baseline OOP, which is significantly more than that in Yuqing ().

Figure 1. Out-of-pocket payments at baseline and final evaluation (by CII durations).

Figure 1. Out-of-pocket payments at baseline and final evaluation (by CII durations).

Discussion

In this study, we have evaluated the effect of the CII systems of two counties in China based on the financial burden and health utilization before and after the implementation of the CII system. The results suggest that CII effectively reduced the OOP payments and medical debt amount, and improved inpatients health utilization with higher frequency of hospital admissions and length of stay. However, the equity improvements provided by CII is somewhat limited.

After the CII, the OOP significantly decreased with adjusting for the covariates. Nearly 10% of total medical expenditure were additionally payed by CIICitation34, which resulted in lower OOP. A systematic review on interventions to reduce illness and injury related financial burden also proved that eliminating or largely reducing copayments in current insurance schemes is effective in reducing OOP medical paymentsCitation35. In all groups, low-income patients had the most OOP reduction after CII. The reason is people with hard economic status usually had higher OOP payments because of limited private health coverage and existing co-morbiditiesCitation1, and CII implemented segmentary reimbursement. The higher the OOP payment after NCMS, the higher the reimbursement rate. Thus, poor patients would get more subsidies in CII.

With a longer duration of CII, more OOP medical payments decreased. This may be because many patients did not understand the policy content when was CII implemented in the first year. With the promotion of CII, the demand for medical services is further released, and more patients benefited from it. The duration of intervention was also an important moderating variable in other studiesCitation36,Citation37, with durations of more than 2 weeks or 12 months being significantly more effective than interventions of shorter duration. But the effect on CHE incidence was limited, only 1.3% patients changed after the CII, and over 95% patients still had catastrophic medical payments. One of the main reasons was lower household income in the final stage. Although CII effectively reduced OOP payments, the household income of patients after the project was less than before (decreased by RMB 20,000). So the CHE incidence did not change a lot. Why had the income decreased after CII? We used the same sampling method for the same sampling area before and after the project. Under the condition of ensuring the scientific study design, the possible reason is that poorer patients would seek health utilization if they had less health expenditure. Many poor people actually give up medical services because of economic shortagesCitation38,Citation39. With the additional compensation of CII, their OOP has dropped significantly, and more poor people will choose treatment, so the average income of the late stage of the project is lower. Our results about the health utilization also support this discussion.

There was an interesting finding in long-term financial burden in this study: after the program, debt incidence increased, but debt value decreased. More patients had medical debt after CII. This may be caused by less OOP payments. With a catastrophic medical cost, households would have to rely on informal healthcare payment arrangements, such as using savings, borrowing money, or selling assetsCitation40. With less medical payments, more patients may try to borrow money for healthcare because they think repaying money is not very difficult. Furthermore, lower OOP payments may also attribute to a lower borrowing amount. Once they had less medical expenditure, they would reduce the debt amount to avoid further negative effects. The CII effectively increases the utilization of health services and reduces the abandonment of treatment due to economic reasons. This is because CII can further reduce financial barriers. Health insurance increases the need for healthcare among patients through the reduction of effective pricesCitation41.

Compared with poor counterparts, patients with middle-income benefited more from health insurance in terms of using inpatient services. This is because the better-off are better equipped to respond to increased medical needs by diverting resources from expendable consumption, whereas the poor are limited in their ability to divert resources from basic and subsistence needsCitation42. Why isn’t it the highest income group or the lowest that have the most growth? Because, for the wealthiest people, there is less potential health services demand. The price elasticity of health service demand is small, and CII will not cause huge changes in service utilization. For low-income patients, although CII may release demand, the constraints, such as income, service quality, access and direct user charge, would prevent the poor from taking advantage of this servicesCitation43. Other studies have similar findings. Hedda Flatø and Huafeng ZhangCitation44 found that richer households enjoyed more increase in healthcare utilization before and after universal health coverage reforms in China, and the CI was increased from 0.065 to 0.069.

With positive change of most indicators, CII improved economic fairness. High OOP and high reimbursement ratio lead to more insurance subsidies for low-income patients, and equity in financing improved. But this ability is limited, and several factors are attributed to this. First, the deductible of CII was RMB 12,000 in Xiantao and RMB 8,000 in Yuqing. This standard was based on local per capita income, but many poor families can’t even pay for the threshold. It was too high for patients to enjoy the subsidies. And this is particularly true when CII only cover the part above the threshold, households must still meet the other part of the costs of care themselvesCitation45. On the other hand, the NCMS benefit package excluded some new and expensive drugs and examinations. But in the fee-for-service payment system, doctors still have strong incentives to prescribe these expensive drugs and examinations. Thus, the expenditure within the benefit package amounted to much less than actual expenditureCitation46. Moreover, policies mandating deductibles, co-payments and ceilings further increased the CHE incidence. There is rich international literature suggesting that public subsidies for health programs frequently benefit richer more than poorer peopleCitation47–49.

Taking into account the economic burden of diseases in low-income people, the government began to enact some pro-poor CII policies. Some regions have tried to lower the deductible line for low-income patients and increase the proportion of reimbursementCitation50. These measures can further improve economic fairness, and Medical Financial Assistance (MFA) specifically for low-income families can alleviate the economic difficulties of these poor people. But fairness is still a problem that cannot be ignored in China and other low- and middle-income countriesCitation24,Citation51, and more measures need to be taken.

This study has several limitations. First, the study was not a randomized controlled study. We evaluated the impact of CII with pooled cross-section data before and after intervention. However, various biases may occur in implementation. National statistics show that the average inpatient cost per admission increased 15.6% over the intervention periodCitation52. The effect of CII on lowering OOP may be under-estimated. Furthermore, China is implementing health system reform, there were multiple concurrent policy interventions that may be synergistic or antagonistic, these confounding factors may make us estimate the role of CII with bias. Second, we only analyzed the patients in the NCMS system who enjoyed the CII in this study, but many poor patients may give up treatment because of poverty. They simply do not reach the deductible line and are not included in the sample. Therefore, we did not get the data of these patients. Third, we assessed the OOP change between two stages upon CII durations, but counties and CII durations are highly collinear, and we cannot judge the determinants of differences in OOP changes over the two periods.

Conclusion

Through the comprehensive measurement of medical burden, this study found that the implementation of CII effectively reduced the burden of patients, including the short-term actual burden of OOP, CHE incidence, the long-term actual burden of medical loans, and the underuse of hospitalization services. It has further improved economic equity. However, the effect of CII on the improvement of fairness is relatively limited. This study suggests that the implementation of CII is necessary, and the Chinese government urgently needs to increase CII funds and extend the healthcare insurance fund investment channel. In the follow-up work, the government should consider more the release of health needs and how to lean toward the poor.

Transparency

Declaration of funding

This study is supported by the National Natural Science Foundation of China: “Study on the Dynamic Optimization of Catastrophic Health Insurance Reimbursement Modes and the Scale of Fund Expenditure in the Perspective of UHC” (Grant No. 71573095).

Declaration of financial/other interests

JJ, YX, LZ, ZZ, XW, and XL are employed by Huazhong University of Science and Technology, Wuhan, China. SC is employed by the Chinese University of Hong Kong, Hong Kong, China. JME peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Acknowledgment

We would like to thank the staff of the Health and Planning Commission of Xiantao county and Yuqing county for their support on the research. We also want to thank the associate editor and reviewers for their careful review and insightful comments, which have led to significant improvement of the manuscript.

References

  • Longo CJ. Equitable access to healthcare services and income replacement for cancer: is critical illness insurance a help or a hindrance? Healthc Policy. 2010;5:e113–e119.
  • Gatzert N, Maegebier A. Critical illness insurances: challenges and opportunities for insurers. Risk Management & Insurance Review. 2015;18(2):255–272.
  • Krause J. Der deutsche markt ist reif für dread disease–teil i das produkt und seine entwicklung. Versicherungswirtschaft. 1998;53:433–438.
  • Cummins JD, Venard B. International Insurance Markets: Between Global Dynamics and Local Contingencies—An Introduction. Handbook of International Insurance; 2007.
  • Company MLI. What are accident and critical illness insurance? 200 Park Avenue, New York, NY 10166: Metropolitan Life Insurance Company; 2017 [accessed 11/18/2018]. Available from: https://www.d47.org/cms/lib/IL01904560/Centricity/Domain/512/Accident_Critical%20Illness%20FAQ.pdf.
  • Re G. Dread Disease-Studie der Gen Re für 2000 bis 2004: Wie Alles Anfing; 2007 [accessed 11/15/2018]. Available from: http://www.genre.com/sharedfile/pdf/Themen15_Droste-de.pdf.
  • Wagstaff A, Lindelow M, Gao J, et al. Extending health insurance to the rural population: an impact evaluation of China's new cooperative medical scheme. J Health Econ. 2009;28:1.
  • Cheng L, Liu H, Zhang Y, et al. The impact of health insurance on health outcomes and spending of the elderly: evidence from China's new cooperative medical scheme. Health Econ. 2015;24:672–691.
  • Ma J, Xu J, Zhang Z, et al. New cooperative medical scheme decreased financial burden but expanded the gap of income-related inequity: evidence from three provinces in rural China. Int J Equity Health. 2016;15:1–11.
  • Fang P, Pan Z, Zhang X, et al. The effect of critical illness insurance in China. Medicine (Baltimore). 2018;97:e11362
  • Guiding Opinions on Carrying out Critical Disease Insurance Work for Urban and Rural Residents 2012 Beijing: China Six ministries and commissions; 2012 [accessed 11/15/2018]. Available from: http://www.gov.cn/gzdt/2012-08/31/content_2214223.htm.
  • Kasemsup V. Health care decisions under budget constraints in Thailand.: elibrary.ru; 2005 [acessed 11/10/2018]. Available from: https://scholar.google.com/scholar?hl=zh-CN&as_sdt=0%2C5&q=Health+care+decisions+under+budget+constraints+in+Thailand.&btnG=
  • Chuma J, Maina T. Catastrophic health care spending and impoverishment in Kenya. BMC Health Serv Res. 2012;12:413
  • Shanchang X. Critical illness insurance: an important link in improving the medical insurance system. Macroeconomic Manag. 2013;03:31–32.
  • Zhou Z, Gao J, Ashley F, et al. Measuring the equity of inpatient utilization in Chinese rural areas. BMC Health Serv Res. 2011;11:201.
  • Tanimura T, Jaramillo E, Weil D, et al. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014;43:1763–1775.
  • Gimenez E, Besses C, Boque C, et al. Indirect and non-medical economic burden, quality-of-life, and disabilities of the myelofibrosis disease in Spain. J Med Econ. 2014;17:435–441.
  • Wagner AK, Graves AJ, Reiss SK, et al. Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. Health Policy. 2011;100:151–158.
  • Galbraith AA, Wong ST, Kim SE, et al. Out‐of‐pocket financial burden for low‐income families with children: socioeconomic disparities and effects of insurance. Health Serv Res. 2005;40:1722–1736.
  • Parish SL, Shattuck PT, Rose RA. Financial burden of raising CSHCN: association with state policy choices. Pediatrics. 2009;124:435–442.
  • Kankeu HT, Saksena P, Xu K, et al. The financial burden from non-communicable diseases in low-and middle-income countries: a literature review. Health Res Policy Sys. 2013;11:31.
  • Galbraith AA, Ross-Degnan D, Soumerai SB, et al. Nearly half of families in high-deductible health plans whose members have chronic conditions face substantial financial burden. Health Aff. 2011;30:322–331.
  • McDaniel PR, Repetti JR. Horizontal and vertical equity: the Musgrave/Kaplow exchange. Fla Tax Rev. 1992;1:607.
  • Balarajan Y, Selvaraj S, Subramanian SV. Health care and equity in India. Lancet. 2011;377:505–515.
  • Meng Q, Xu L, Zhang Y, et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet. 2012;379:805–814.
  • Mcintyre D, Thiede M, Dahlgren G, et al. What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts? Soc Sci Med. 2006;62:858–865.
  • Limwattananon S, Tangcharoensathien V, Prakongsai P. Catastrophic and poverty impacts of health payments: results from national household surveys in Thailand. Bull World Health Organ. 2007;85:600.
  • Xu K, Evans DB, Kawabata K, et al. Household catastrophic health expenditure: a multicountry analysis. Lancet. 2003;362:111–117.
  • Xiang L, Pan Y, Hou S, et al. The impact of the new cooperative medical scheme on financial burden of tuberculosis patients: evidence from six counties in China. Infect Dis Poverty. 2016;5:8.
  • Zhou C, Long Q, Chen J, et al. The effect of NCMS on catastrophic health expenditure and impoverishment from tuberculosis care in China. Int J Equity Health. 2016;15:172.
  • Leive A, Xu K. Coping with out-of-pocket health payments: empirical evidence from 15 African countries. Bull World Health Org. 2008;86:849–856C.
  • Litwin H, Sapir EV. Forgone health care due to cost among older adults in European countries and in Israel. Eur J Ageing. 2009;6:167–176.
  • Fleurbaey M, Schokkaert E. Equity in health and health care. In Handbook of health economics 2011; (Vol. 2, pp. 1003–1092). Elsevier.
  • Duan Ting GG, Shen W, Jia J, et al. Analysis of benefits and implementation effect of new rural cooperative disease insurance system—taking Jilin province as an example. China Health Policy Res. 2014;7:43–47.
  • Essue BM, Kimman M, Svenstrup N, et al. The effectiveness of interventions to reduce the household economic burden of illness and injury: a systematic review. Bull WHO. 2015;93:102–112.
  • Rehse B, Pukrop R. Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. Patient Edu Couns. 2003;50:179–186.
  • Higa DH, Gary M, Nicole C, et al. Interventions to improve retention in HIV primary care: a systematic review of U.S. studies. Curr Hiv/Aids Rep. 2012;9:313–325.
  • Baughman KR, Burke RC, Hewit MS, et al. Associations between difficulty paying medical bills and forgone medical and prescription drug care. Popul Health Manag. 2015;18:358.
  • Home C. QuickStats: delayed or forgone medical care because of cost concerns among adults aged 18–64 years, by disability and health insurance coverage status — national health interview survey. United States, 2009. Morb Mortal Wkly Rep. 2010;59:1456.
  • Russell S. Illuminating cases: understanding the economic burden of illness through case study household research. Health Policy Plann. 2005;20:277–289.
  • Hidayat B, Thabrany H, Dong H, et al. The effects of mandatory health insurance on equity in access to outpatient care in Indonesia. Health Policy Plan. 2004;19:322–335.
  • Roy K, Howard DH. Equity in out-of-pocket payments for hospital care: evidence from India. Health Policy. 2007;80:297–307.
  • Castroleal F, Dayton J, Demery L, et al. Public social spending in Africa: do the poor benefit? World Bank Res Obs. 1999;14:49–72.
  • Flatø H, H Z. Inequity in level of healthcare utilization before and after universal health coverage reforms in China: evidence from household surveys in Sichuan Province. Int J Equity Health. 2016;15:96.
  • World Health Organization. Designing health financing systems to reduce catastrophic health expenditure (No. WHO/EIP/HSF/PB/05.02). Geneva: World Health Organization; 2005.
  • Hu S, Tang S, Liu Y, et al. Reform of how health care is paid for in China: challenges and opportunities. Lancet. 2008;372:1846
  • Victora CG, Wagstaff A, Schellenberg JA, et al. Applying an equity lens to child health and mortality: more of the same is not enough. Lancet. 2003;29:233–241.
  • O’Donnell O, Van Doorslaer E, Rannaneliya RP, et al. The Incidence of public spending on healthcare: comparative evidence from Asia. World Bank Econ Rev. 2007;21:93–123.
  • Liu X, Tang S, Yu B, et al. Can rural health insurance improve equity in health care utilization? a comparison between China and Vietnam. Int J Equity Health. 2012;11:1–9.
  • Gansu Province urban and rural residents critical illness insurance work implementation plan (2018 version) 2018. Gansu province: Gansu Provincial People's Government; 2018 [acessed 10/20/2018]. Available from: http://www.gsws.gov.cn/single/11117/74854.html.
  • Tang S, Meng Q, Chen L, et al. Tackling the challenges to health equity in China. Lancet. 2008;372:1493–1501.
  • National statistical bulletin on health and family planning 2013 Beijing: National Health and Family Planning Commission of the People's Republic of China; [accessed 11/10/2018]. Available from: http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2013/helpheader.html.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.